Hyphens Pharma International Limited (SGX:1J5)
Singapore · Delayed Price · Currency is SGD 0.3500
-0.0050 (-1.41%)
At close: Jul 27, 2026
SGXC:1J5 Financials Overview
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 177.37 | 177.37 | 195.42 | 170.6 | 162.32 | 125.88 |
Revenue Growth | -9.24% | -9.24% | 14.55% | 5.10% | 28.94% | 4.06% |
Gross Profit Gross Profit Growth | 68.3 | 68.3 | 68.24 | 61.03 | 62.28 | 47.41 |
Operating Income Operating Income Growth | 11.91 | 11.91 | 13.27 | 11.01 | 14.45 | 7.79 |
Net Income Net Income Growth | 5.84 | 5.84 | 10.19 | 8.57 | 11.35 | 6.85 |
Earnings Per Share EPS Growth | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 |
EPS Growth | -42.59% | -42.59% | 16.97% | -24.32% | 61.23% | 10.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical and Medical Aesthetics Pharmaceutical and Medical Aesthetics Growth | 101.33 | 101.33 | 124.25 | 102.2 | 95.66 | 65.62 |
Proprietary Brands Proprietary Brands Growth | 36.67 | 36.67 | 27.55 | 25.65 | 23.44 | 19.07 |
Digital Platform and E-Pharmacy Digital Platform and E-Pharmacy Growth | 39.37 | 39.37 | 43.63 | 42.75 | 43.22 | 41.19 |
Total Total Growth | 177.37 | 177.37 | 195.42 | 170.6 | 162.32 | 125.88 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 26.83 | 26.83 | 23.42 | 23.37 | 36.48 | 19.46 |
Total Debt Total Debt Growth | 9.43 | 9.43 | 14.11 | 6.82 | 5.67 | 8.17 |
Net Cash (Debt) Net Cash Growth | 17.41 | 17.41 | 9.31 | 16.55 | 30.81 | 11.29 |
Net Cash Growth | 87.04% | 87.04% | -43.76% | -46.29% | 172.85% | -49.93% |
Net Cash Per Share Net Cash Per Share Growth | 0.06 | 0.06 | 0.03 | 0.05 | 0.10 | 0.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18.75 | 18.75 | 0.06 | 5.65 | 16.88 | 6.04 |
Capital Expenditures CapEx Growth | -0.76 | -0.76 | -1.18 | -0.3 | -0.56 | -0.7 |
Free Cash Flow Free Cash Flow Growth | 17.99 | 17.99 | -1.12 | 5.34 | 16.32 | 5.34 |
Free Cash Flow Growth | - | - | - | -67.27% | 205.77% | 41.98% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.51% | 38.51% | 34.92% | 35.77% | 38.37% | 37.66% |
Operating Margin | 6.72% | 6.72% | 6.79% | 6.46% | 8.90% | 6.19% |
Pretax Margin | 4.55% | 4.55% | 6.63% | 6.19% | 8.80% | 6.56% |
Profit Margin | 3.29% | 3.29% | 5.22% | 5.02% | 6.99% | 5.44% |
FCF Margin | 10.14% | 10.14% | -0.57% | 3.13% | 10.05% | 4.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.015 | 0.015 | 0.015 | 0.009 | 0.011 | 0.007 |
Dividend Per Share Growth | 0% | 0% | 74.42% | -22.52% | 65.67% | 8.06% |
Dividend Yield | 4.23% | 4.67% | 5.79% | 3.43% | 4.41% | 3.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.82 | 17.71 | 8.64 | 10.29 | 9.11 | 13.53 |
Forward PE | 8.75 | 8.77 | 7.75 | 8.88 | 9.49 | 12.88 |
P/FCF Ratio | 6.01 | 5.75 | - | 16.50 | 6.34 | 17.36 |
PS Ratio | 0.61 | 0.58 | 0.45 | 0.52 | 0.64 | 0.74 |